Status:
UNKNOWN
Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History.
Lead Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Collaborating Sponsors:
University of Padova
Institut Curie
Conditions:
Desmoid
Desmoid; Abdominal
Eligibility:
FEMALE
18+ years
Brief Summary
Desmoid tumors (DT) are rare disease of intermediate malignancy with variable and often unpredictable clinical course. There is a growing interest in defining potential risk of recurrence or progressi...
Detailed Description
Background. Desmoid tumors (DT) are rare disease of intermediate malignancy with variable and often unpredictable clinical course. A significant proportion of female patients with a diagnosis of DT h...
Eligibility Criteria
Inclusion
- histologically-proven DT;
- female patients
- fertile age, \>18 years;
- concomitant or subsequent pregnancy (study group), or no history of pregnancy (screening group).
Exclusion
- suspected DT without histological diagnosis • male patients affected by DT
- \<18 years old, and non-fertile age.
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 15 2023
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05284305
Start Date
March 1 2022
End Date
May 15 2023
Last Update
January 27 2023
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women Hospital / Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02115
2
Mount Sinai Hospital/Toronto University
Toronto, Canada, M5G 1X5
3
Institut Curie
Paris, France
4
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy, 20133